A Phase II Study of Anlotinib in STS Patients
Clinical trial NCT01878448 · COMPLETED
Trial details
- NCT number
- NCT01878448
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-10-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.